PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50322F80018Leukine 250mcg VIL INJ — Partner Therapeutics, Inc

Partner Therapeutics, Inc holds $147.4M across 9 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award under parent 36F79718D0593. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Mar 29, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Aspr/Orm-Sns
Awarding office
Partner Therapeutics, Inc
Recipient
Mar 29, 2024
PoP end
$59M
Obligated
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract number75A50322F80018
Also listed as36F79718D0593-75A50322F80018
AgencyAspr/Orm-Sns
Awarding officeAspr/Orm-Sns
IncumbentPartner Therapeutics, Inc
UEIJ33MSDBJZMC6
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79718D0593
Place of performanceBOSTON, MA
PoP end (current)Mar 29, 2024
Obligated$59M

LEUKINE 250MCG/VIL INJ is a federal award for Aspr/Orm-Sns held by Partner Therapeutics, Inc. Estimated value $59M ($59M obligated). Current period of performance ends Mar 29, 2024. Last award drew 1 bidder. Place of performance: BOSTON, MA.

Recompete timing

Public
● Past PoP end (915 days ago)

Current PoP ended Mar 29, 2024 (915 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 75A50322F80018? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Partner Therapeutics, Inc — $147.4M obligated across 9 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($147.4M) · all agencies
Department of Health and Human Services (HHS)$147.3M · 100%Department of Veterans Affairs (VA)$163K · 0%
Open full company profile →

Related awards

Same parent · incumbent
75A50323F80027
LEUKINE 250MCG VIL INJ (5PKG)
$133.5M
Sep 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50322F80018?

75A50322F80018 (Leukine 250mcg VIL INJ) is a Aspr/Orm-Sns award with an estimated value of $59M, currently held by Partner Therapeutics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50322F80018?

Aspr/Orm-Sns awarded 75A50322F80018 to Partner Therapeutics, Inc.

Who is the incumbent on 75A50322F80018?

Partner Therapeutics, Inc is the incumbent with $147.4M across 9 related awards in SCOUT’s public footprint. The current period of performance ends Mar 29, 2024.

When does Partner Therapeutics, Inc’s 75A50322F80018 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 29, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50322F80018? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50322F80018